Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Leukemia/Lymphoma/Myeloma 1243

1243 - The value of 18F-FDG PET (/CT) in the patients with post-transplant lymphoproliferative disorder (PTLD) (ID 584)

Session Name
Lymphoma / Leukemia / Myeloma Posters
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Leukemia/Lymphoma/Myeloma
Presentation Number
1243

Previous Eposter
1240 - High Resolution Breast PET as an invaluable tool to diagnose new breast cancer lesions in patients with dense breast (ID 750)

Next Eposters
1255 - Post-treatment surveillance using FDG PET/CT in head and neck squamouscell carcinoma (ID 607)
1258 - Is F18-FDG PET useful in Surveillance of Head and Neck Cancer (ID 610)
1274 - Differential Diagnostic value of Intensity- and Volume-based Parameters of 18F-FDG PET/CT in Primary Cardiac Tumors with Increased 18F-FDG uptake (ID 667)
1277 - Voxel-based personalized dosimetry in Y-90 microsphere radioembolization - comparison between Monte Carlo simulation method and conventional partition model (ID 655)
1280 - Predicting Efficacy of Radium-223 Dichrolide (223RaCl2) therapy in Bone-metastatic Castration-resistant Prostate Cancer Using F-18 Sodium Fluoride (18F-NaF) PET/CT. (ID 656)
1282 - Does 18F-FDG-PET/CT Improve Detection and Management of Cancers with Unknown Primary Site? (ID 666)
1284 - Uptake changes on the whole-body dynamic18F-FDG PET may assess tissue characterization. Comparison with the conventional delayed scan. (ID 657)
1286 - Patterns of vessel involvement in patients referred for possible Giant Cell Arteritis on PET/CT (ID 726)
1287 - Predicting outcome of repair for posterior medial meniscus root tear with early osteoarthritis using bone SPECT/CT (ID 727)
1290 - Uptake of [11C]PBR28 and translocator protein specificity in Inflammatory Joint disease (ID 730)